Increase public health campaigns to boost vaccination rates, particularly among vulnerable populations.
Pandemics
Pandemics Risk
Assessment for this date
The current pandemic risk is moderate due to rising respiratory virus activity, persistent vaccine hesitancy, and ongoing outbreaks of various infectious diseases.
February 9, 2026
Trend
Viewing the record for February 9, 2026 within the full trend.
Risk Drivers
What is pushing the current reading.
The threat level is influenced by several factors: the increase in flu and RSV cases in the US and Europe, persistent vaccine hesitancy affecting COVID and flu vaccination rates, and the emergence of new infectious disease threats such as avian flu and MERS. Despite the availability of effective vaccines, uptake remains suboptimal, particularly among older adults, which could exacerbate the spread of these viruses. Additionally, misinformation and political influences continue to impact public health responses and vaccination efforts. Surveillance and response systems are in place but face challenges due to these factors, maintaining a moderate risk level.
Risk Reduction Actions
Priority actions generated from the current analysis.
Enhance surveillance and rapid response capabilities to manage rising cases of flu, RSV, and other respiratory viruses.
Address vaccine misinformation by providing clear, evidence-based information to the public.
Accelerate the development and deployment of universal vaccines for flu and other emerging pathogens.
Collaborate internationally to monitor and respond to cross-border outbreaks and emerging infectious diseases.
Sources Monitored
Visible feeds used in this category's nightly run.
Selected Articles
Supporting articles referenced in the latest score.
- 2024-25 COVID vaccine 80% effective against death, CDC estimates
- Large share of older US adults haven’t had a recent flu or COVID vaccine, poll finds
- After 3-week decline, flu cases rise across the US; RSV, COVID activity high in certain states
- US respiratory virus activity reaches high levels as flu, RSV spread
- Study finds that despite broad COVID vaccine availability, COVID still deadlier than flu in hospitalized patients